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Abstract
Background: Antibiotics are given empirically for suspected 
sepsis in up to 75% of neonates on the Neonatal and Paediatric 
Intensive Care Unit (NPICU), after completion of a septic screen. 
Treatment is discontinued on day 3 if cultures remain negative 
or after 7-14 days with proven sepsis and, until recently, these 
neonates are then observed for an additional period of 24 hours 
before being discharged from hospital.
Aim: To assess whether the 24 hour observation period after 
stopping antibiotics is clinically justified and, if not, whether 
neonates can be discharged safely on the same day when 
antibiotics are stopped.
Methods: A consecutive sample of 95 babies admitted to 
NPICU, and who received antibiotics, from December 2006 
to January 2008 were analysed prospectively. Their clinical 
presentation, predisposing risk factors for neonatal sepsis, 
investigations, antibiotic details and medical management 
including respiratory support were recorded, and correlated 
with all events that may have occurred during the observation 
period after stopping antibiotics.  
Results: No adverse events were documented in the 24 
hour period after antibiotics in all 95 neonates in this study 
and, therefore, there was no association with any potential 
predisposing risk factors. 
Conclusion: The need to observe neonates for a period 
prior to discharge after stopping antibiotics is not supported 
on clinical grounds and, as a result of this study, has been 
discontinued. Neonates can be discharged from hospital safely 
and immediately on stopping antibiotics, thus reducing hospital 
stay and an estimated cost saving of approximately €18,000 to 
the service provider per annum.
Introduction
Neonatal sepsis is classified into early onset (infection 
occurring in the first 5 days of life) and late onset (after 5 days of 
age).1,2  Early and late bacterial sepsis in the neonatal period often 
involve different micro-organisms but both can be a major cause 
of morbidity and, if untreated, carry a mortality of 50%.3 The 
presentation of neonatal sepsis is often non-specific,4 although 
acute onset with rapid, often catastrophic clinical deterioration 
is common, especially in preterm infants and those with very low 
birthweight (<1500g).5 Commonly isolated organisms include 
coagulase negative staphylococci, Staphylococcus aureus, 
Streptococcus agalactiae and Escherichia coli. 
In contrast to the approach in older children, neonates are 
presumed septic with minimal clinical suspicion.4 Consequently, 
up to 75% of all neonates admitted to NPICU, Mater Dei 
Hospital, Malta, undergo at least one septic screen, usually 
including blood and cerebrospinal fluid cultures,6 immediately 
followed by empiric broad spectrum antibiotics designed to 
cover the more common organisms.7-9  Based on the prevailing 
infecting organisms on our NPICU, benzylpenicillin and 
cefuroxime are administered as empiric ‘first line’ antibiotics, 
whereas co-amoxiclav and cefotaxime empirical ‘second line’ 
antibiotics if meningitis is suspected and meropenem and 
teicoplanin as ‘third line’ if there is no apparent response to 
the above antibiotics. Although a bacterial cause is confirmed 
in less than 10% of these infants, antibiotics are continued for 
at least 72 hours until cultures and indicators of sepsis (e.g. 
C-reactive protein: CRP)6 are reported to be negative. Confirmed 
sepsis necessitates a 7-14 day course of appropriate antibiotics, 
according to the organism and site of infection.7
Until recently, it was Unit practice for neonates to be 
observed in hospital for a further 24 hours once antibiotics 
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were discontinued, regardless of whether these were started 
empirically or following positive cultures. This antibiotic-free 
period was observed even though there were no indicators 
of sepsis. However, although this policy was written into the 
antibiotic-sepsis protocol for the Unit, it was not evidence-
based and this study was designed to evaluate whether it is 
clinically justified and, therefore, whether the practice could 
be stopped safely.
Methods
All neonates aged >32 completed weeks gestation admitted 
to the NPICU and who were started on antibiotics for suspected 
or proven sepsis from December 2006 to January 2008 were 
analysed prospectively.  For all cases, data related to the 
immediate antenatal history, the infant, investigations and 
management were documented (Table 1).  Adverse events were 
defined as any events that occurred after stopping antibiotics 
during the 24 hour ‘observation period’ and, if adverse events did 
occur, all details relating to these events were documented. This 
study set out to determine whether there was any relationship 
between any patient data and discontinuing antibiotic therapy 
and any observed adverse effects thereafter. 
Premature infants aged <32 weeks gestation were excluded 
from the study because, in this group, factors other than 
antibiotic therapy (with or without an observation period after 
stopping antibiotics), determine the time of discharge from 
hospital (e.g. attainment of a gestational age of ≥35 weeks 
and weight ≥2000g). Furthermore, once off all therapeutic 
treatment, it is unit practice to encourage these babies to ‘room 
in’ with their parents for between 1-3 nights prior to discharge. 
Chi squared was applied to compare the association of any 
adverse events during the observation period, taking p≤0.05 
to be statistically significant.
Results  
During the study period, a cohort of 95 cases out of 297 
admissions to the NPICU fulfilled the entry criteria. Of these, 69 
were males and 26 females with a gestation of 32 to 43 completed 
weeks (mean 34.75 weeks, median 38 weeks), and birth weight of 
1.51 - 4.75kg (mean 2.97kg, median 2.95kg, SD 0.64). As shown 
in Table 2, predisposing risk factors present in the mothers, 
duration of ruptured membranes and mode of delivery were 
not associated with any adverse effects on stopping antibiotics. 
Similarly, no parameter relating to the infant’s gestation, birth 
weight, Apgar score and clinical condition requiring admission, 
investigations and management was observed to be associated 
with any adverse events after stopping antibiotics.
On admission to NPICU, empirical first line benzylpenicillin 
and cefuroxime were administered in 70 (74%) cases, co-
amoxiclav and cefotaxime (empirical second line antibiotic) in 
21 (22%) cases, and 4 others received different antimicrobials 
according to sensitivities. One infant included in this group also 
received acyclovir for 14 days for suspected herpes infection. First 
line antibiotic cover was subsequently changed to second line in 
6 infants and changed to third line antibiotics (meropenem and 
teicoplanin) in 1 infant, following a rise in CRP, growth in blood 
cultures or deterioration in the clinical condition.
The duration of antibiotic treatment ranged from 2 to 
14 days (mean 4.9 days, median 5 days, SD2.2). In 24 (25%) 
and 53 (56%) cases, antibiotics were stopped after 72 and 120 
hours, respectively, as serial CRPs and blood cultures remained 
negative. Eighteen cases required antibiotics for longer periods, 
ranging from 7-14 days, due to confirmed or strongly suspected 
sepsis.
Of the 95 infants who received antibiotics, 26 (27%) infants 
did not require any respiratory support, 13 (14%) needed oxygen 
via nasal prongs, 52 (55%) had nasal continuous positive airway 
pressure (CPAP) and 4 (4%) cases required intermittent positive 
pressure ventilation.
Adverse events
 After stopping antibiotics and prior to discharge from 
hospital, neonates were observed without treatment on the 
NPICU (52 cases) or postnatal ward (43 cases) for periods of 
observation ranging from 0.5-13 days (mean 1.8 days, median 
1 day, SD 2.2). The majority (73) were observed for 24 hours 
before discharge. The length of observation was longer in 22 
others due to other factors including prematurity, inadequate 
weight gain and feeding difficulties.
No adverse events were recorded after stopping antibiotics 
in any of the 95 neonates studied, including those who had had 
a difficult neonatal course requiring ventilation and prolonged 
courses of antibiotics because of documented sepsis (Table 2).
Discussion
Although several neonates are investigated for sepsis, only 
3–8% will be found to have culture-proven infection, translating 
into an incidence of just 2 in 1,000 live births.1,7 However, since 
Table 1: Data collected relating to patients, 
investigations and management
General data
Maternal health during pregnancy, time of rupture of 
membranes before delivery
Infant data
Date of birth, gender, gestation, birth weight, mode of 
delivery, Apgar score at 1 and 5 minutes 
age at admission to NPICU, temperature on admission, 
symptoms and signs on admission
Investigations
White cell, neutrophil and platelet counts, sequential 
CRPs, blood, urine and CSF cultures, chest X-ray
Management 
Type of central line, mode and duration of respiratory 
support (if any), any other support (e.g. inotropes) 
type and duration (in days) of antibiotics
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the early signs of sepsis in the newborn are often non-specific 4 
and the consequences of untreated sepsis are often dire,3 many 
newborns undergo diagnostic ‘septic screens’ and the initiation 
of antibiotic treatment empirically, and certainly before the 
diagnosis can be determined on culture.7-9  In our unit, this 
practice is carried out in 75% of admissions to NPICU.
The risk factors for neonatal bacterial sepsis as listed in Table 
3 are well documented.1,5,7 Many of these risk factors are common 
and, therefore, empiric antibiotic use in neonates is justified.7-9 
Equally important, however, is the discontinuation of these 
antibiotics as soon as possible if sepsis is not confirmed and, 
therefore, they are no longer required.  Indeed, prolongation 
Table 2: Association between cohort characteristics and risk factors with observed adverse effects
Documented parameter Details Association with
   adverse effects
Cohort (n=95) • 69 male; 26 female
 • gestation 32 to 43 completed weeks (mean 34.75, median 38 weeks) 
 • birth weight: 1.51 - 4.75kg (mean 2.97kg, median 2.95kg, SD 0.64)  None
Mothers (n=95) • 5 group B streptococcal (GBS) colonisation; 4 fever during delivery; 
  2 foul smelling liquor (but culture negative); 1 genital herpes; 
  1 rubella seroconversion during pregnancy; 1 parvovirus infection  None
Rupture membranes • 0 (elective LSCS) to 216 hours (mean 7.1hr, median 1.5hr, SD 24)
 • four cases had prolonged rupture of membranes > 24 hours  None
Delivery • 33 born vaginally, 5 ventouse, 25 elective LSCS, 32 emergency LSCS 
 • 82 had Apgar scores ≥7 at 1 & 5 minutes; 13 had score ≤6 at 1 or 5 min None
Admission NPICU • age at admission: 0.5 hours to 6 days (mean 8.5hr, median 2hr, SD 20)
 • 62 babies normothermic, 30 hypothermic (<36.5oC), 3 febrile (>37.5oC)
 • 68 (72%) respiratory distress; 9 (10%) with cyanosis, 
  6 vomiting and feeding problems, 5 omphalitis, 3 fever, 1 convulsions  None
Investigations • total white cell range: 4.7-34.6x109/l with 19 cases abnormally raised
 • neutrophils: 1.5-17.8x109/l with 10 cases having an abnormal count1
 • 8 thrombocytopenia below <150 x 109/l 
 • CRP was positive (>10) in 11 cases (range 14-181)  None
Microbiology • Positive blood cultures in 12 cases but only 2 with Serratia marcescens 
  and Staphylococcus aureus had raised CRP; other pathogens included 
  5 Staphylococcus albus*, 3 Enterococcus faecalis, 1 Moraxella osteolensis, 
  1 Group B Streptococcus  (*NB:  blood cultures collected by open drip method 
  accounting for number of presumed contaminants)
 • CSF and urine cultures in 8 cases were all negative 
 • chest X ray showed increased hilar markings in 30 from total 90 cases, 
  confirmed to be within normal limits by reporting radiologists  None
Management • 24 (25%) had indwelling central catheters (18 umbilical arterial, 
  5 umbilical venous, 2 radial arterial lines and 1 femoral venous line)
 • benzylpenicillin + cefuroxime administered in 70 (74%) cases; 
  co-amoxyclav + cefotaxime in 21 (22%) cases; 4 others received 
  different antimicrobials according to sensitivities 
 • 1 infant included received acyclovir for 14 days for suspected herpes
 • 6 infants received further antibiotics (meropenem + teicoplanin) 
  following a rise in CRP, growth in blood cultures or deterioration 
  in the clinical condition
 • antibiotic duration 2 to 14 days (mean 4.9 days, median 5 days, SD2.2); 
  in 24 and 53 cases, antibiotics stopped after 72, 120 hours, respectively. 
  18 required antibiotics for 7-14 days, due to confirmed sepsis
 • 26 infants needed no respiratory support, 13 nasal prong oxygen, 
  52 nasal CPAP, 4 cases required intermittent positive pressure ventilation None
Legend: SD=standard deviation; LSCS=lower segment caesarian section; CRP=C reactive protein; CPAP=continuous positive airway pressure
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Table 3: Risk factors for bacterial sepsis in neonates
Newborn risks Maternal risks Others
Prematurity Premature rupture membranes  Poor antenatal care
Very low birth weight (<1000g) Prolonged rupture membranes Poor maternal nutrition
Male>female Maternal GBS Substance abuse
Low Apgar score (<6 at 1 & 5min) Maternal fever >38.4oC 
Perinatal asphyxia Chorioamnionitis  
Meconium staining Urinary infection 
Congenital anomalies  
Legend: GBS=Group B streptococcus
of unnecessary antibiotics has been shown to be associated 
with, for example, greatly increased colonisation with gram 
negative bacilli when antibiotics are continued for more than 
3 days.10 Similarly, prophylactic antibiotic use to cover an 
invasive device such as an intercostal drain, umbilical arterial 
or venous catheter, does not prevent sepsis and is only likely 
to select for multi-resistant organisms.11,12  Hence, if systemic 
cultures are negative, antibiotics should be stopped after 48 
hours. This is usually possible, particularly if automated blood 
culturing systems are used, but delays of up to 5 days for a final 
culture result are observed where this system is not established, 
resulting in lengthier administration of empiric antibiotics. 
Indeed, cessation of antibiotics at the earliest opportunity is 
widely established and has not been shown to be associated 
with a recurrence or the emergence of breakthrough sepsis.7 
However, the additional ‘safety measure’ adopted by our Unit for 
a further period of observation in hospital for potential adverse 
effects is not evidence-based. Despite the study’s limitations in 
a lack of a control group and failure to blind the authors to the 
treatment the infants’ received, this study did not report any 
adverse effects during the precautionary period of observation. 
Indeed, this study analysed several known risk factors, itemised 
above, that may have resulted in complications after stopping 
antibiotics: yet, in all the cases, no events were recorded in the 24 
hour period of observation, regardless of gender, weight, mode 
of delivery, Apgar score, respiratory support, documented or 
suspected sepsis, days and type of antibiotics received.
Conclusion
This study therefore challenges the current practice for a 
period of pre-discharge observation, and strongly supports the 
practice whereby neonates with a mean age of 38 weeks and 
without other confounding problems, can be safely discharged 
home on the same day as stopping antibiotics. As a result of this 
study, the discontinuation of this unnecessary practice would 
have reduced the average stay in hospital for 73 out of the total of 
95 infants in the study cohort by 24 hours. This translates into a 
cost saving on hospital stay of approximately €18,000 (including 
bed stay and consumables) for this group of patients and, in turn, 
a similar recurrent saving for the unit each year. Clearly, earlier 
discharge would also minimise anxiety and inconvenience to 
the family and, for all these reasons, the 24 hour precautionary 
observation period has now been discontinued.
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